MX2009005444A - Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. - Google Patents

Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Info

Publication number
MX2009005444A
MX2009005444A MX2009005444A MX2009005444A MX2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A
Authority
MX
Mexico
Prior art keywords
steroidal
delivery system
hydrophilic drug
vinyl acetate
polymer
Prior art date
Application number
MX2009005444A
Other languages
English (en)
Spanish (es)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005444A publication Critical patent/MX2009005444A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009005444A 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. MX2009005444A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062626 WO2008062008A1 (en) 2006-11-22 2007-11-21 Delivery system for a non-steroidal non-ionized hydrophilic drug

Publications (1)

Publication Number Publication Date
MX2009005444A true MX2009005444A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Country Status (6)

Country Link
US (2) US20100203104A1 (OSRAM)
EP (2) EP2094270A1 (OSRAM)
JP (2) JP2010510286A (OSRAM)
CA (2) CA2670157A1 (OSRAM)
MX (2) MX2009005444A (OSRAM)
WO (2) WO2008062008A1 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
US20080160065A1 (en) * 2006-07-12 2008-07-03 Janet Anne Halliday Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
MX2009005444A (es) * 2006-11-22 2009-06-02 Organon Nv Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
WO2010039722A1 (en) * 2008-09-30 2010-04-08 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of risperidone and methods of use thereof
WO2010105093A2 (en) * 2009-03-12 2010-09-16 Delpor, Inc. Implantable device for long-term delivery of drugs
ES2699200T3 (es) 2010-03-16 2019-02-07 Titan Pharmaceuticals Inc Dispositivos implantables heterogéneos de administración de fármacos
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
AU2019275406B2 (en) 2018-05-24 2024-11-14 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
SG11202005949UA (en) * 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US12472148B2 (en) 2021-04-26 2025-11-18 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
WO1997002015A1 (en) * 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
CA2442281C (en) * 2001-03-27 2010-06-08 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
IL166687A0 (en) * 2002-08-30 2006-01-15 Alza Corp Embossable and writable multilaminate backing construction
EP2633853A1 (en) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
BRPI0509146B8 (pt) * 2004-03-24 2021-05-25 Merck Sharp & Dohme sistema de liberação de droga, método de fabricação do mesmo, e, uso do sistema de liberação de droga
RS53890B1 (sr) * 2004-11-10 2015-08-31 Tolmar Therapeutics, Inc. Stabilizovan polimerni sistem za isporuku
EP2091541A1 (en) * 2006-11-22 2009-08-26 N.V. Organon Vaginal delivery system for mirtazapine
MX2009005444A (es) * 2006-11-22 2009-06-02 Organon Nv Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Also Published As

Publication number Publication date
EP2094348A1 (en) 2009-09-02
US20100104619A1 (en) 2010-04-29
JP2010510286A (ja) 2010-04-02
JP2010510287A (ja) 2010-04-02
CA2670157A1 (en) 2008-05-29
CA2670454A1 (en) 2008-05-29
WO2008062008A1 (en) 2008-05-29
MX2009005445A (es) 2009-06-02
EP2094270A1 (en) 2009-09-02
US20100203104A1 (en) 2010-08-12
WO2008062009A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
MX2009005444A (es) Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
JP2010510286A5 (OSRAM)
Almeida et al. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs
NZ628828A (en) Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
WO2004112748A3 (en) Rate controlled release of a pharmaceutical agent in a biodegradable device
WO2008129106A3 (es) Nanopartículas que comprenden una ciclodextrina y una molécula biológicamente activa y sus aplicaciones
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2008100375A3 (en) Polymer-based films and drug delivery systems made therefrom
TW200616589A (en) Transdermal delivery of drugs based on crystal size
MX2019003443A (es) Peliculas permeables con propiedades de barrera microbiana.
SI2905014T1 (en) An intrauterine delivery system for contraception
MXPA05013138A (es) Composiciones adhesivas, articulos que incorporan las mismas y metodos de manufactura de las mismas.
WO2008153611A3 (en) Sustained delivery formulations of risperidone compounds
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
ATE459345T1 (de) Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
WO2007041584A3 (en) Implantable sensors, implantable pumps, and anti-scarring drug combinations
WO2009039262A3 (en) Steroid containing ophthalmic drug delivery systems
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2007131193A3 (en) Main chain acid-degradable polymers for the delivery of bioactive materials
MX2017000588A (es) Composicion antiadherente.
WO2007112436A3 (en) Use of polymeric materials with other substances for improved performance
WO2004112713A3 (en) Drug polymer complexes
WO2009148580A3 (en) Controlled release copolymer formulation with improved release kinetics

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal